Clark Capital Management Group, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 175 filers reported holding HAEMONETICS CORP in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Clark Capital Management Group, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2014$229,000
-25.4%
7,024
-3.5%
0.02%
-20.0%
Q4 2013$307,000
+2.7%
7,281
-2.8%
0.02%
+4.2%
Q3 2013$299,000
-6.0%
7,490
-2.5%
0.02%
-17.2%
Q2 2013$318,0007,6820.03%
Other shareholders
HAEMONETICS CORP shareholders Q2 2014
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders